Related Experiment Videos

Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation

Takao Ohtsuka1, Hoon Ryu, Yohji A Minamishima

  • 1Hematology and Oncology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.

Oncogene
|March 19, 2003
PubMed

Insights

Cyclin G negatively impacts the stability of tumor suppressor proteins p53 and p73. This regulation affects cell cycle arrest, highlighting cyclin G's role in cancer pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cyclin G is a transcriptional target of tumor suppressor p53.
  • Its precise function in the p53-Mdm2 regulatory loop is not fully understood.

Purpose of the Study:

  • To investigate the role of cyclin G in regulating the stability of p53 and p73 proteins.
  • To elucidate the mechanism by which cyclin G affects cell cycle control.

Main Methods:

  • Expression of cyclin G in cell lines (MCF7, Saos2).
  • Analysis of p53 and p73 protein levels and cell cycle progression.
  • Interaction studies between cyclin G, p53, and p73.
  • Use of small interfering RNA (siRNA) to inhibit cyclin G.

Main Results:

  • Cyclin G expression decreased p53 and p73 protein levels and abrogated DNA damage-induced cell cycle arrest.
  • Cyclin G directly interacts with p53 and p73, mediating their downregulation.
  • Mdm2 is involved in cyclin G-mediated p53 reduction but not p73.
  • siRNA-mediated inhibition of cyclin G led to p53 and p73 accumulation.

Conclusions:

  • Cyclin G negatively regulates the stability of p53 family proteins.
  • Cyclin G's action is independent of ubiquitination or transcriptional control, suggesting a novel regulatory mechanism.
  • Cyclin G plays a critical role in the p53-Mdm2 autoregulated module and cell cycle control.

Related Concept Videos